SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-20-000020
Filing Date
2020-04-06
Accepted
2020-04-06 08:41:52
Documents
14
Period of Report
2020-04-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20200403form8xk.htm   iXBRL 8-K 47384
  Complete submission text file 0001280600-20-000020.txt   188722

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20200403.xsd EX-101.SCH 4465
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20200403_cal.xml EX-101.CAL 634
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20200403_def.xml EX-101.DEF 1484
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20200403_lab.xml EX-101.LAB 26147
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20200403_pre.xml EX-101.PRE 13590
13 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20200403form8xk_htm.xml XML 4486
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 20775847
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences